Envoy Medical Inc. has announced the issuance of three new patents in Australia, further bolstering its intellectual property portfolio. The patents include Australian Patent No. 2021391396, titled "Implantable Cochlear Implant Stimulation Calibration," focusing on cochlear implant systems with a testing circuit for current calibration during stimulation. Another, Australian Patent No. 2021390456, titled "Combination Hearing Aid and Cochlear Implant System," addresses the integration of cochlear implants with external hearing aids to improve simultaneous operation. The third, Australian Patent No. 2022227534, titled "Recharge System for Implantable Battery," involves systems for predicting thermal doses and optimizing charging conditions for implanted rechargeable batteries.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。